DJIA 18,080.14 21.45 0.12%
NASDAQ 5,092.09 36.02 0.71%
S&P 500 2,117.69 4.76 0.23%
market minute promo

4.10 -0.20 (-4.65%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

THLD $4.10 -4.65%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.31
Previous Close $4.30
Daily Range $4.10 - $4.31
52-Week Range $2.58 - $5.41
Market Cap $292.2M
P/E Ratio -8.78
Dividend (Yield) $0.00 (0.0%)
Volume 529,364
Average Daily Volume 519,328
Current FY EPS -$0.48

Sector

Healthcare

Industry

Drug Makers

THRESHOLD PHARMACEUTICALS, INC. (THLD) Description

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer. Website: http://www.thresholdpharm.com/

News & Commentary Rss Feed

5 Promising Biotech Stocks Under $10

Don't let their share price fool you. These five biotech stocks have the potential to double your money many times over if their product pipelines meet expectations.

Health Care Sector Update for 04/22/2015: OMED, HLS, THLD

Threshold Pharma Offers Preclinical Data Suggesting TH-4000 Could Overcome Resistance to Conventiona

Threshold Pharma Offers Preclinical Data Suggesting TH-4000 Could Overcome Resistance to Conventional EGFR Tyrosin Kinase Inhibitors

Mid-Day Market Update: Starwood Hotels Jumps Following CEO Resignation; CoStar Group Shares Slide

Threshold Pharmaceuticals Raises Cash - An Inside Look At The Deal

Health Care Sector Update for 02/12/2015: PLX, THLD, ACOR

In Case You Missed It, Researchers May Have Discovered a New Method to Treat Cancer

We know chemotherapy kills cancer cells, but it's also an indiscriminate killer of healthy cells. According to a new study released this past week, an entirely new treatment pathway could eliminate a significant portion of healthy cell death.

Did Researchers Just Discover the Cause of Pancreatic Cancer?

Pancreatic cancer is the fourth-leading cause of cancer-related death, but researchers may have moved one step closer to discovering a cure this past week.

Twitter's Favorite Biotech and Pharma Stocks

Consensus? We don't need no stinking consensus!

Health Care Sector Update for 11/17/2014: INO, THLD, AZN

See More THLD News...

THLD's Top Competitors

THLD $4.10 (-4.65%)
Current stock: THLD
AMGN $167.91 (-0.74%)
Current stock: AMGN
GILD $103.70 (-1.44%)
Current stock: GILD
BIIB $401.71 (-6.64%)
Current stock: BIIB